Oct. 15 at 9:33 PM
$ALT For those "hoping" that
$ALT addresses Fibrosis, why not just buy the one that shows positive effects on Fibrosis Improvement. For those that are worried about being under in your
$ALT bet, just realize if you had taken your 50% loss when
$ALT's Failed their trial endpoint and bought
$IVA, you would have made your money back, and then some. You would have also been aligned with a P3 asset that will likely get approved, rather than a failed asset that you hope the FDA looks the other way on.
Emotional investing is destroying y'all. It's not too late to correct a wrong. And for those "waiting until 48W data" or "EoP2 Meeting", you'll lose more money. I expect a 36% drop on the 48W data, and FDA to hammer
$ALT with a huge trial coming out of the EoP2 meeting, which means
$ALT will drag you along like they did with their Failed Obesity Program.
Follow/Subscribe for more suggestions and perspective. Would love to hear yours too.
Let's make some money. Cheers!
$XBI $MDGL $VKTX
